Furthermore, inhibition of the VEGF/VEGFR1 axis affects mTOR, Akt, and STAT-3 phosphorylation, c-Myc levels, and the activity of the translation initiation factor, eIF4E, suggesting that bevacizumab is active on different MM cells pathways including proteostasis [40]. Here, VEGFA is linked to Miyoshi myopathy.